Murat GÜNER, Nurullah DAMBURACI, Mehmet GÜNDOĞAN, Utku Dönem DİLLİ, Coşkun Ege OĞUZER, Barış SEVİNÇ

Primer dalak anjisorkom olgu sunumu ve literatür eşliğinde değerlendirme

Primer dalak anjiosarkom nadir görülen , sık metastaz yapabilen ,kötü prognozlu, agresif bir neoplazidir. Tümör hücreleri endotelyal markerlar (CD31, CD34, and faktör VIII) ile güçlü pozitiflik göstermektedir.Erken dönemde asemptomatik olduğu için hastalar ancak rastlantısal olarak veya karın içi kanama bulguları gibi nedenlerle geç dönemde tanı alabilmektedir.Erken tanı ve cerrahi girişim en etkili tedavi yöntemidir.Kabul edilen tedavi yöntemi splenektomidir.Bu çalışmada kliniğimize karın ağrısı ile başvuran ve primer dalak anjiosarkom tanısı alan hasta literatür eşliğinde değerlendirilmiştir.

Anahtar Kelimeler:

dalak, anjiosarkom, splenektomi

Primary Splenic angiosarcoma a case report and literature review

Primary splenic angiosarcoma is a very aggressive neoplasm with poor prognosis due to its very high frequency of metastasis. The tumor cells exhibit a strong positivity for at least one of the endothelial markers (CD31, CD34, and factor VIII). The diagnosis is usually difficult and late because the patient remains asymptomatic till the onset of massive intra-abdominal bleeding. Early diagnosis and surgical management is the only potentially long –term therapeutic option. The current and accepted therapy is splenectomy. Herein, we report a case of primary splenic angiosarcoma that presented with abdominal pain, along with a review of the current literature.

Keywords:

spleen, anjiosarcoma, splenectomy,

PDF

___

Hamid KS, Rodriguez JA, Lairmore TC. Primary splenic angiosarcoma. JSLS. 2010;14(3):431–5.
Neuhauser TS, Derringer GA, Thompson LD, Fanburg-Smith JC, Miettinen M, Saaristo A and Abbondanzo SL. Splenic angiosarcoma: a clinicopathologic and immunophenotypic study of 28 cases. Mod Pathol 2000; 13: 978-987.
Manouras A, Giannopoulos P, Toufektzian L, Markogiannakis H, Lagoudianakis EE, Papadima A, et al. Splenic rupture as the presenting manifestation of primary splenic angiosarcoma in a teenage woman: a case report. J Med Case Rep. 2008;2:133.
Venegas LF, Pohlmann PR, Balbinot AL, Schuck E, de Oliveira CTM, Frank KJ, Dillemburg CF, da Costa MSB, Rivero LFR, Pütten ACK: Angiossarcoma primário de baço: relato de caso e revisão da literatura. Rev Bras Cancerolog 1998;44:12–14.
Shukla M, Basu S, Shukla VK, Kumar M. Fever, anaemia, and splenomegaly: A rare presentation of splenic angiosarcoma. Indian J Med Paediatr Oncol. 2011;32:230-32.
Falk S, Krishnan J and Meis JM. Primary angiosarcoma of the spleen. A clinicopathologic study of 40 cases. Am J Surg Pathol 1993; 17: 959-970.
Alt B, Hafez GR, Trigg M, Shahidi NT and Gilbert EF. Angiosarcoma of the liver and spleen in an infant. Pediatr Pathol 1985; 4: 331-339.
Plotnik AN, Schweder P, Tsui A and Kavar B. Splenic angiosarcoma metastasis to the brain. J Clin Neurosci 2008; 15: 927-929.
Zwi LJ, Evans DJ, Wechsler AL, Catovsky D. Splenic angiosarcoma following chemotherapy for follicular lymphoma. Hum Pathol 1986; 17: 528-530 [PMID: 3516861 DOI: 10.1016/ S0046-8177(86)80044-2]
Z. Kamocki, A. Steward, K. P. Zareba, A. Kukli´nski, and B. Kedra, “Primary splenic angiosarcoma—the same diagnosis yielding two different clinical pictures. Case report,” Contemporary Oncology, vol. 17, no. 2, pp. 218–221, 2013.
K. Yoshida, T. Endo, K. Kamata et al., “A case of angiosarcoma of the spleen with intraperitoneal bleeding,” Nihon Shokakibyo Gakkai Zasshi, vol. 111, pp. 549–556, 2014.
Autry JR, Weitzner S. Haemangiosarcoma of spleen with spontaneous rupture. Cancer. 1975;35:534-39.
Thompson WM, Levy AD, Aguilera NS, Gorospe L, Abbott RM. Angiosarcoma of the spleen: imaging characteristics in 12 patients. Radiology 2005; 235: 106-115 [PMID: 15749977 DOI: 10.1148/ radiol.2351040308]
Vrachliotis TG, Bennett WF, Vaswani KK, Niemann TH, Bova JG. Primary angiosarcoma of the spleen--CT, MR, and sonographic characteristics: report of two cases. Abdom Imaging 2000; 25: 283-285 [PMID: 10823452 DOI: 10.1007/s002610000034]
Keogan MT, Freed KS, Paulson EK, et al: Imaging-guided percutaneous biopsy of focal splenic lesions: update on safety and effectiveness. AJR Am J Roentgenol 1999;172:933–937.
Metser U, Even-Sapir E: The role of 18F-FDG PET/CT in the evaluation of solid splenic masses. Semin Ultrasound CT MR 2006;27:420–425.
Delacruz V, Jorda M, Gomez-Fernandez C, Benedetto P and Ganjei P. Fine-needle aspiration diagnosis of angiosarcoma of the spleen: a case report and review of the literature. Arch Pathol Lab Med 2005; 129: 1054-1056.
Young RJ, Brown NJ, Reed MW, Hughes D and Woll PJ. Angiosarcoma. Lancet Oncol 2010; 11: 983-991.
Hara T, Tsurumi H, Kasahara S, Ogawa K,Takada J, Imai K, et al. Long-term survival of a patient with splenic angiosarcoma after resection, high-dose chemotherapy, and autologous peripheral blood stem cell transplantation. Intern Med. 2010;49:2253-57.
P. Montemayor and V. Caggiano, “Primary hemangiosarcoma of the spleen associated with leukocytosis and abnormal spleen scan,” International Surgery, vol. 65, no. 4, pp. 369–373, 1980.
Naka N, Ohsawa M, Tomita Y, Kanno H, Uchida A, Myoui A, Aozasa K. Prognostic factors in angiosarcoma: a multivariate analysis of 55 cases. J Surg Oncol 1996; 61: 170-176 [PMID: 8637202]
Targarona EM, Espert JJ, Balague C, Piulachs J, Artigas V, Trias M: Splenomegaly should not be considered a contraindication for laparoscopic splenectomy. Ann Surg 1998;228:35–39.
Penel N, Bui BN, Bay JO, Cupissol D, Ray-Coquar I, Piperno-Neumann S, et al. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. J Clin Oncol. 2008;26:5269-74.
Mehren M, Randall RL, Benjamin RS, et al. NCCN clinical practice guiedlines inoncology (soft tissue sarcoma), 2015